On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now


Sigma Labs Inc. (NASDAQ: SGLB) Presented PrintRite3D Software with Materialize Control Platform at Formnext 2019

  • Sigma Labs proprietary software featured at major global 3D-printing conference
  • Presentation showcased version 5.2 of the software, which features several software enhancements
  • Partnership validates Sigma Labs’ software as a leading additive-manufacturing solution

Sigma Labs Inc. (NASDAQ: SGLB), a leading producer of quality-assurance software for the commercial 3D-printing industry, demonstrated the latest version of its proprietary technology PrintRite3D(R) in collaboration with Materialise NV at the Formnext 2019 conference held in Frankfurt, Germany, on November 19-22.

As a pioneer in the 3D-printing, quality-assurance domain, Sigma Labs partnered with Materialise, one of the most innovative developers of additive-manufacturing software and printing solutions. The two companies joined forces to integrate their innovative technologies in response to the growing need for more control and increased productivity in 3D printing, which should enable broader adoption and scalability of additive manufacturing. Combining Sigma Labs’ advanced quality-control technology with in-situ process monitoring for metal 3D printing will give customers maximal control of the production process.

Formnext is the premier global exhibition and conference dedicated to 3D printing and the next generation of intelligent industrial production. During the three-day event, experts from a wide range of industries such as aerospace, mechanical engineering, automotive, electrical engineering and medical technology gathered to discover and explore advancements in additive manufacturing, industrial 3D printing and related upstream and downstream processes.

At the event, Sigma Labs’ chief technology officer Darren Beckett presented on “The Integration of PrintRite3D Melt Pool Monitoring Software with Materialise’s Machine Control Platform (MCP) for Advanced Process Control.” The presentation showcased version 5.2 of the software, which features several software enhancements including the automated anomaly detection with Z connectivity that identifies thermal defects which propagate across multiple layers and enhanced data-trend analysis and customizable thresholding that enable automatic alerts. These new functionalities should further strengthen the capabilities of additive manufacturing for serial production.

Materialise incorporates more than 25 years of additive-manufacturing experience into a broad range of software solutions and 3D-printing services, which together form the foundation of the 3D-printing industry. Headquartered in Belgium with branches worldwide, Materialise leverages the largest group of software developers in the industry with one of the largest, global, 3D-printing facilities. Recognized as one of the prominent technology leaders in the 3D-printing space, Materialise has impacted entire industries including aerospace, health care, automotive, art and design, and consumer goods. The company recognizes PrintRite3D as the leading quality-assurance software that, when combined with Materialise Control Platform (MCP), can enable a unique, integrated product solution for volume manufacturing.

The partnership between the two companies validates Sigma Labs’ software as the leading solution for the additive-manufacturing industry, positioning Sigma labs at the forefront of the industry.

Sigma Labs was founded in 2010 and has since become the go-to, 3D-printing expert for real-time, computer-aided inspection (CAI) solutions. Managed by experts from many different science disciplines such as metallurgy, physics, signal processing, mechanical engineering, optics, software AI and ML, data analytics and visualization, the company established credibility within highly demanding industries such as aerospace, defense, biomedical and transportation.

For more information, visit the company’s website at www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

From Our Blog

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is “One to Watch”

September 25, 2020

CNS Pharmaceuticals’ lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and currently incurable form of brain cancer. In a Phase I clinical trial of Berubicin in malignant brain tumors, 44% of patients experienced a statistically significant improvement in clinical benefit. In preclinical studies, the company’s second drug candidate, […]

Rotate your device 90° to view site.